CD8A and Lymphadenopathy: Inspection of lymph nodes and spleen and quantitation of CD4+, CD8+ and CD4−CD8−B220+ DN T cells showed that the Fas C194V transgene completely protected mice from the lymphadenopathy and splenomegaly that arises in Fas-deficient lpr/lpr mice.